OCGN FY 2014 Earnings — Ocugen, Inc. Revenue & Financial Results | Market Cap Arena

OCGNOcugen, Inc.

$754M

FY 2014 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

$0

Operating Income

-$33M

Net Income

-$23M

EPS (Diluted)

$-891.47

Cash Flow

Operating Cash Flow

-$18M

Free Cash Flow

-$22M

Stock-Based Comp.

$547,000

Balance Sheet

Total Assets

$65M

Total Liabilities

$11M

Stockholders' Equity

$54M

Cash & Equivalents

$58M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$8,000	-100.0%
Gross Profit	$0	$8,000	-100.0%
Operating Income	-$33M	-$17M	-93.9%
Net Income	-$23M	-$26M	+11.4%